SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001019687-08-003034
Filing Date
2008-07-14
Accepted
2008-07-14 16:06:59
Documents
6
Period of Report
2008-04-30

Document Format Files

Seq Description Document Type Size
1 PEREGRINE PHARMACEUTICALS, INC. peregrine_10k-043008.htm 10-K 1887747
2 SUBSIDIARIES peregrine_10k-ex2100.htm EX-21 2993
3 CONSENT peregrine_10k-ex2301.htm EX-23.1 3708
4 CERTIFICATION peregrine_10k-ex3101.htm EX-31.1 10873
5 CERTIFICATION peregrine_10k-ex3102.htm EX-31.2 10677
6 CERTIFICATION peregrine_10k-ex3200.htm EX-32 12321
  Complete submission text file 0001019687-08-003034.txt   1929922
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-K | Act: 34 | File No.: 001-32839 | Film No.: 08950900
SIC: 2835 In Vitro & In Vivo Diagnostic Substances